U.S. Markets closed

Vanda Pharmaceuticals says its schizophrenia drug works in bipolar disorder

Vanda Pharmaceuticals says its schizophrenia drug works in bipolar disorder

“We believe this is really critical data to ask for an FDA approval,” said Vanda’s president and CEO.